期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

COX-2抑制剂在乳腺癌药物治疗中的研究进展

Advancement of COX-2 inhibitior in breast cancer medication
下载PDF
导出
摘要 环氧化酶-2(COX-2)在乳腺癌细胞中过度表达,影响乳腺癌的发生、发展和预后,可作为预防和治疗的靶分子。选择性COX-2抑制剂可联合化疗、内分泌治疗及生物治疗等,作为肿瘤治疗的辅助药物应用于临床,为乳腺癌的治疗提供一种新的途径。 Cyclooxygenase-2 overexpresses in breast cancer, and is related to its genesis, development and prognosis. Selective COX-2 inhibitors can combine with chemotherapy, endocrine therapy and biotherapy. It is gradually used for adjunctive therapy and provides a new pathway for the therapy of breast cancer.
作者 邓婷 胡春宏
机构地区 中南大学湘雅二医院肿瘤科
出处 《国际病理科学与临床杂志》 CAS 2006年第5期383-386,共4页 Journal of International Pathology and Clinical Medicine
关键词 环氧化酶-2 环氧化酶-2抑制剂 乳腺癌 cyclooxygenase-2 cyclooxyenase-2 inhibitor breast cancer
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献24

  • 1Half E, Tang X M, Gwyn K, et al. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ [ J ].Cancer Res, 2002, 62 (6):1676-168t.
  • 2Spizzo G, Gastt G, Wolf D, et al. Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival[J]. Br J Cancer, 2003, 88 (4) : 574-578.
  • 3Denkert C, Winzer K J, Muller B M, et al. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma [ J ].Cancer, 2003, 97 (12): 2978-2987.
  • 4Boland G P, Butt I S, Prasad R, et al. COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ[J]. Br J Cancer, 2004, 90 (2) :423-429.
  • 5Munkarah A R, Morris R, Baumann P, et al. Effects of prostaglandin E2 on proliferation and apoptosis of epithelial ovarian cancer cells[J]. J Soc Gynecol Investig, 2002, 9(3) :168-173.
  • 6Amano H, Hayashi I, Endo H, et al. Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth[J]. J Exp Med, 2003, 197(2) :221-232.
  • 7Sivula A, Talvensaafi-Mattila A, Lundin J, et al. Association of cyclooxygenase-2 and matrix metallopmteinase-2 expression in human breast cancer[J]. Breast Cancer Res Treat, 2005, 89(3) :215 -220.
  • 8Liu C H, Chang S H, Narko K, et al. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice[J]. J Biol Chem, 2001,276: 18563-18569.
  • 9Ristimaki A, Sivula A, Lundin J, et al. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer [ J ]. Cancer Res, 2002, 62 (3):632-635.
  • 10Chow LWC, Toi M. Prospective pilot study of the preoperative use of celecoxib ( CELEBREX ) and FEC for the treatment of locally advanced breast cancer[ M ]. San Antonio : [ s. n. ], 2002.
国际病理科学与临床杂志
2006年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部